Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Targeting cancer stem cells via dendritic-cell vaccination
Complex evaluation of human monocyte-derived dendritic cells for cancer immunotherapy
Heat shock proteins (HSPs) based anti-cancer vaccines
Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity
[Immunotherapy with hyperthermia for advanced or recurrent breast cancer patients in whom standard therapy showed no effect or was refused]
Ascorbic acid alleviates toxicity of paclitaxel without interfering with the anticancer efficacy in mice
Selenoprotein P status correlates to cancer-specific mortality in renal cancer patients
Dendritic cell-based immunotherapy in mesothelioma
Dendritic cell-based tumor vaccinations in epithelial ovarian cancer: a systematic review
Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone
Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
Two avirulent, lentogenic strains of Newcastle disease virus are cytotoxic for some human pancreatic tumor lines in vitro
Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer
Immunotherapy in ovarian cancer
NK cells: key to success of DC-based cancer vaccines?
The use of oncolytic viruses to overcome lung cancer drug resistance
Morphologic evidence of anti-tumor specificity of T cells activated by denritic cells derived from peripheral blood mononuclear cells of thyroid cancer patients
Dendritic cell vaccine modified by Ag85A gene enhances anti-tumor immunity against bladder cancer
Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial
Newcastle disease virus: a promising agent for tumour immunotherapy